The ROE as of November 2024 (TTM) for REGENXBIO Inc. (RGNX) is -70.65%

According to REGENXBIO Inc.’s latest financial reports and current stock price. The company's current ROE is -70.65%. This represents a change of 295.94% compared to the average of -17.84% of the last 4 quarters.

REGENXBIO Inc. (RGNX) Historical ROE (quarterly & annually)

How has RGNX ROE performed in the past?

The mean historical ROE of REGENXBIO Inc. over the last ten years is -17.21%. The current -70.65% ROE has changed 310.43% with respect to the historical average. Over the past ten years (40 quarters), RGNX's ROE was at its highest in in the December 2014 quarter at 41.00%. The ROE was at its lowest in in the December 2023 quarter at -20.17%.

REGENXBIO Inc. (RGNX) ROE by Quarter and Year

Discovering the peaks and valleys of REGENXBIO Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

REGENXBIO Inc. (RGNX) Average ROE

How has RGNX ROE performed in the past?

The current ROE of REGENXBIO Inc. (RGNX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

REGENXBIO Inc. (RGNX) ROE vs. Peers

How is RGNX’s ROE compared to its peers?

REGENXBIO Inc.’s ROE is greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than Replimune Group, Inc. (-53.12%), greater than Mirum Pharmaceuticals, Inc. (-41.22%), greater than Rocket Pharmaceuticals, Inc. (-62.62%), greater than Avidity Biosciences, Inc. (-27.66%), greater than uniQure N.V. (-188.82%), less than Protagonist Therapeutics, Inc. (34.68%), greater than Pliant Therapeutics, Inc. (-48.91%), greater than Immunocore Holdings plc (-14.67%), greater than Revolution Medicines, Inc. (-33.67%), greater than Monte Rosa Therapeutics, Inc. (-62.68%), greater than Stoke Therapeutics, Inc. (-54.45%), greater than AN2 Therapeutics, Inc. (-57.63%), greater than Passage Bio, Inc. (-72.53%), greater than 4D Molecular Therapeutics, Inc. (-28.00%), greater than Crinetics Pharmaceuticals, Inc. (-36.12%), greater than LianBio (-21.53%), greater than Kezar Life Sciences, Inc. (-59.73%),

Build a custom stock screener for REGENXBIO Inc. (RGNX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like REGENXBIO Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

REGENXBIO Inc. (RGNX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like REGENXBIO Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.